$219.91 Million in Sales Expected for Omega Healthcare Investors Inc (OHI) This Quarter

Share on StockTwits

Brokerages predict that Omega Healthcare Investors Inc (NYSE:OHI) will announce sales of $219.91 million for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Omega Healthcare Investors’ earnings, with the lowest sales estimate coming in at $215.24 million and the highest estimate coming in at $222.40 million. Omega Healthcare Investors reported sales of $219.64 million during the same quarter last year, which indicates a positive year-over-year growth rate of 0.1%. The company is expected to announce its next quarterly earnings report on Monday, October 29th.

On average, analysts expect that Omega Healthcare Investors will report full-year sales of $870.34 million for the current fiscal year, with estimates ranging from $822.00 million to $887.10 million. For the next fiscal year, analysts anticipate that the business will report sales of $889.85 million, with estimates ranging from $811.00 million to $917.50 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Omega Healthcare Investors.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Friday, August 3rd. The real estate investment trust reported $0.75 EPS for the quarter, topping the consensus estimate of $0.73 by $0.02. The firm had revenue of $192.85 million for the quarter, compared to analysts’ expectations of $200.30 million. Omega Healthcare Investors had a net margin of 10.61% and a return on equity of 2.49%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.87 EPS.

A number of equities research analysts have recently issued reports on OHI shares. Mitsubishi UFJ Financial Group reaffirmed a “neutral” rating on shares of Omega Healthcare Investors in a report on Tuesday, October 2nd. MED started coverage on shares of Omega Healthcare Investors in a report on Tuesday, October 2nd. They issued a “neutral” rating and a $31.00 target price on the stock. They noted that the move was a valuation call. Zacks Investment Research cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Tuesday. Wells Fargo & Co cut shares of Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a report on Monday, June 25th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $34.00 target price on shares of Omega Healthcare Investors in a report on Monday, August 6th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $30.87.

Hedge funds have recently modified their holdings of the company. Daiwa Securities Group Inc. grew its stake in Omega Healthcare Investors by 43.9% in the 2nd quarter. Daiwa Securities Group Inc. now owns 5,032,761 shares of the real estate investment trust’s stock valued at $156,015,000 after buying an additional 1,536,523 shares during the last quarter. Scout Investments Inc. grew its stake in Omega Healthcare Investors by 355.2% in the 2nd quarter. Scout Investments Inc. now owns 1,130,335 shares of the real estate investment trust’s stock valued at $35,040,000 after buying an additional 882,039 shares during the last quarter. Cornerstone Wealth Management LLC grew its stake in Omega Healthcare Investors by 3,000.0% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 909,261 shares of the real estate investment trust’s stock valued at $29,331,000 after buying an additional 879,930 shares during the last quarter. First Republic Investment Management Inc. grew its stake in Omega Healthcare Investors by 2,344.6% in the 2nd quarter. First Republic Investment Management Inc. now owns 881,585 shares of the real estate investment trust’s stock valued at $27,329,000 after buying an additional 845,523 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in Omega Healthcare Investors by 14.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock valued at $176,373,000 after buying an additional 736,393 shares during the last quarter. 72.25% of the stock is currently owned by institutional investors.

Shares of OHI stock traded down $0.14 on Monday, reaching $31.98. The stock had a trading volume of 1,717,362 shares, compared to its average volume of 1,901,612. The company has a debt-to-equity ratio of 1.15, a quick ratio of 4.03 and a current ratio of 4.03. The stock has a market cap of $6.57 billion, a price-to-earnings ratio of 9.69, a PEG ratio of 5.51 and a beta of 0.29. Omega Healthcare Investors has a 12 month low of $24.90 and a 12 month high of $33.63.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

See Also: How Do You Make Money With Penny Stocks?

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply